Lidia Fonseca - Feb 27, 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role
Executive Vice President
Signature
/s/ Shanice A. Reid, by power of atty, for Lidia Fonseca
Stock symbol
PFE
Transactions as of
Feb 27, 2025
Transactions value $
-$1,816,580
Form type
4
Date filed
3/3/2025, 05:36 PM
Previous filing
Sep 16, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $2.27M +72.6K +186.68% $31.31 112K Feb 27, 2025 Direct F1
transaction PFE Common Stock Tax liability -$43.9K -1.68K -1.51% $26.10 110K Feb 27, 2025 Direct F2
transaction PFE Common Stock Tax liability -$1.77M -68K -61.92% $26.06 41.8K Feb 27, 2025 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise -$2.27M -72.6K -100% $31.31 0 Feb 27, 2025 Common Stock 72.6K $31.31 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.

Remarks:

lfxpoa24.htm